Skip to main content
Top
Published in: Diagnostic Pathology 1/2011

Open Access 01-12-2011 | Short report

Early onset sebaceous carcinoma

Authors: Dongjin Sung, Sara A Kaltreider, Federico Gonzalez-Fernandez

Published in: Diagnostic Pathology | Issue 1/2011

Login to get access

Abstract

Background

Ocular sebaceous carcinoma can masquerade as benign lesions resulting in delay of diagnosis. Early recognition is even more difficult in young patients where the disease rarely occurs. Here, we provide a clinicopathological correlation of ocular sebaceous carcinoma in a young individual lacking history of hereditary cancer or immunosuppression.

Findings

A detailed histopathological study including p53 DNA sequencing was performed on an aggressive sebaceous carcinoma presenting in a healthy 32 year-old Caucasian woman. She had no history of retinoblastoma, evidence for a hereditary cancer syndrome, or radiation therapy. However, she potentially was at risk for excessive UV light exposure. A detailed review of the literature is also provided.
A moderately well differentiated sebaceous carcinoma was established histopathologically arising from the meibomian gland of the upper eyelid. In most areas, the cytoplasm contained small but distinct Oil-red-O positive vacuoles. Direct sequencing of p53 identified a G:C→A:T mutation at a dipyrimidine site. The mutation results in substitution of arginine for the highly conserved glycine at residue 199 located at the p53 dimer-dimer interface. Energy minimization structural modeling predicts that G199R will neutralize negative charges contributed by nearby inter- and intramonomeric glutamate residues.

Discussion

This study points to the importance of recognizing that sebaceous carcinoma can occur in young patients with no evidence for hereditary cancer risk or radiation therapy. The G199R substitution is anticipated to alter the stability of the p53 tetrameric complex. The role of UV light in the etiology of sebaceous carcinoma deserves further study. Our findings, taken together with those of others, suggest that different environmental factors could lead to the development of sebaceous carcinoma in different patients.

Virtual Slides

The virtual slide(s) for this article can be found here: http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​1227870450349458​.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dasgupta T, Wilson LD, Yu JB: A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009, 115 (1): 158-165. 10.1002/cncr.23952.CrossRefPubMed Dasgupta T, Wilson LD, Yu JB: A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009, 115 (1): 158-165. 10.1002/cncr.23952.CrossRefPubMed
2.
go back to reference Kass LG, Hornblass A: Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989, 33 (6): 477-490. 10.1016/0039-6257(89)90049-0.CrossRefPubMed Kass LG, Hornblass A: Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989, 33 (6): 477-490. 10.1016/0039-6257(89)90049-0.CrossRefPubMed
3.
go back to reference Gonzalez-Fernandez F, Kaltreider SA, Patnaik BD, Retief JD, Bao Y, Newman S, Stoler MH, Levine PA: Sebaceous carcinoma. Tumor progression through mutational inactivation of p53. Ophthalmology. 1998, 105 (3): 497-506. 10.1016/S0161-6420(98)93034-2.CrossRefPubMed Gonzalez-Fernandez F, Kaltreider SA, Patnaik BD, Retief JD, Bao Y, Newman S, Stoler MH, Levine PA: Sebaceous carcinoma. Tumor progression through mutational inactivation of p53. Ophthalmology. 1998, 105 (3): 497-506. 10.1016/S0161-6420(98)93034-2.CrossRefPubMed
4.
go back to reference Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL: Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005, 50 (2): 103-122. 10.1016/j.survophthal.2004.12.008.CrossRefPubMed Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL: Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005, 50 (2): 103-122. 10.1016/j.survophthal.2004.12.008.CrossRefPubMed
5.
go back to reference Honavar S, Shields C, Maus M, Shields J, Demirci H, Eagle R: Primary intraepithelial sebaceous gland carcinoma of the palpebral conjunctiva. Archives of ophthalmology. 2001, 119 (5): 764-CrossRefPubMed Honavar S, Shields C, Maus M, Shields J, Demirci H, Eagle R: Primary intraepithelial sebaceous gland carcinoma of the palpebral conjunctiva. Archives of ophthalmology. 2001, 119 (5): 764-CrossRefPubMed
6.
go back to reference Yamamoto N, Mizoe JE, Hasegawa A, Ohshima K, Tsujii H: Primary sebaceous carcinoma of the lacrimal gland treated by carbon ion radiotherapy. Int J Clin Oncol. 2003, 8 (6): 386-390. 10.1007/s10147-003-0348-2.CrossRefPubMed Yamamoto N, Mizoe JE, Hasegawa A, Ohshima K, Tsujii H: Primary sebaceous carcinoma of the lacrimal gland treated by carbon ion radiotherapy. Int J Clin Oncol. 2003, 8 (6): 386-390. 10.1007/s10147-003-0348-2.CrossRefPubMed
7.
go back to reference Yoon JS, Kim SH, Lee CS, Lew H, Lee SY: Clinicopathological analysis of periocular sebaceous gland carcinoma. Ophthalmologica. 2007, 221 (5): 331-339. 10.1159/000104764.CrossRefPubMed Yoon JS, Kim SH, Lee CS, Lew H, Lee SY: Clinicopathological analysis of periocular sebaceous gland carcinoma. Ophthalmologica. 2007, 221 (5): 331-339. 10.1159/000104764.CrossRefPubMed
8.
go back to reference Zurcher M, Hintschich CR, Garner A, Bunce C, Collin JR: Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol. 1998, 82 (9): 1049-1055. 10.1136/bjo.82.9.1049.PubMedCentralCrossRefPubMed Zurcher M, Hintschich CR, Garner A, Bunce C, Collin JR: Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol. 1998, 82 (9): 1049-1055. 10.1136/bjo.82.9.1049.PubMedCentralCrossRefPubMed
9.
go back to reference Ni C, Searl SS, Kuo PK, Chu FR, Chong CS, Albert DM: Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin. 1982, 22 (1): 23-61. 10.1097/00004397-198202210-00006.CrossRefPubMed Ni C, Searl SS, Kuo PK, Chu FR, Chong CS, Albert DM: Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin. 1982, 22 (1): 23-61. 10.1097/00004397-198202210-00006.CrossRefPubMed
10.
go back to reference Font RL, Rishi K: Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome. Ophthalmology. 2003, 110 (9): 1833-1836. 10.1016/S0161-6420(03)00578-5.CrossRefPubMed Font RL, Rishi K: Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome. Ophthalmology. 2003, 110 (9): 1833-1836. 10.1016/S0161-6420(03)00578-5.CrossRefPubMed
11.
go back to reference Jakobiec FA, Zimmerman LE, La Piana F, Hornblass A, Breffeilh RA, Lackey JK: Unusual eyelid tumors with sebaceous differentiation in the Muir-Torre syndrome. Rapid clinical regrowth and frank squamous transformation after biopsy. Ophthalmology. 1988, 95 (11): 1543-1548.CrossRefPubMed Jakobiec FA, Zimmerman LE, La Piana F, Hornblass A, Breffeilh RA, Lackey JK: Unusual eyelid tumors with sebaceous differentiation in the Muir-Torre syndrome. Rapid clinical regrowth and frank squamous transformation after biopsy. Ophthalmology. 1988, 95 (11): 1543-1548.CrossRefPubMed
12.
go back to reference Rishi K, Font RL: Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review. Ophthal Plast Reconstr Surg. 2004, 20 (1): 31-36. 10.1097/01.IOP.0000103009.79852.BD.CrossRefPubMed Rishi K, Font RL: Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review. Ophthal Plast Reconstr Surg. 2004, 20 (1): 31-36. 10.1097/01.IOP.0000103009.79852.BD.CrossRefPubMed
13.
go back to reference Tay E, Schofield JB, Rowell NP, Jones CA: Ophthalmic presentation of the Muir Torre syndrome. Ophthal Plast Reconstr Surg. 2003, 19 (5): 402-404. 10.1097/01.IOP.0000087068.21749.43.CrossRefPubMed Tay E, Schofield JB, Rowell NP, Jones CA: Ophthalmic presentation of the Muir Torre syndrome. Ophthal Plast Reconstr Surg. 2003, 19 (5): 402-404. 10.1097/01.IOP.0000087068.21749.43.CrossRefPubMed
14.
go back to reference Rulon DB, Helwig EB: Cutaneous sebaceous neoplasms. Cancer. 1974, 33 (1): 82-102. 10.1002/1097-0142(197401)33:1<82::AID-CNCR2820330115>3.0.CO;2-4.CrossRefPubMed Rulon DB, Helwig EB: Cutaneous sebaceous neoplasms. Cancer. 1974, 33 (1): 82-102. 10.1002/1097-0142(197401)33:1<82::AID-CNCR2820330115>3.0.CO;2-4.CrossRefPubMed
15.
go back to reference Kiyosaki K, Nakada C, Hijiya N, Tsukamoto Y, Matsuura K, Nakatsuka K, Daa T, Yokoyama S, Imaizumi M, Moriyama M: Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest Ophthalmol Vis Sci. 2010, 51 (1): 7-11. 10.1167/iovs.09-4127.CrossRefPubMed Kiyosaki K, Nakada C, Hijiya N, Tsukamoto Y, Matsuura K, Nakatsuka K, Daa T, Yokoyama S, Imaizumi M, Moriyama M: Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest Ophthalmol Vis Sci. 2010, 51 (1): 7-11. 10.1167/iovs.09-4127.CrossRefPubMed
16.
go back to reference Kivela T, Asko-Seljavaara S, Pihkala U, Hovi L, Heikkonen J: Sebaceous carcinoma of the eyelid associated with retinoblastoma. Ophthalmology. 2001, 108 (6): 1124-1128. 10.1016/S0161-6420(01)00555-3.CrossRefPubMed Kivela T, Asko-Seljavaara S, Pihkala U, Hovi L, Heikkonen J: Sebaceous carcinoma of the eyelid associated with retinoblastoma. Ophthalmology. 2001, 108 (6): 1124-1128. 10.1016/S0161-6420(01)00555-3.CrossRefPubMed
17.
go back to reference Yen MT, Tse DT: Sebaceous cell carcinoma of the eyelid and the human immunodeficiency virus. Ophthal Plast Reconstr Surg. 2000, 16 (3): 206-210. 10.1097/00002341-200005000-00007.CrossRefPubMed Yen MT, Tse DT: Sebaceous cell carcinoma of the eyelid and the human immunodeficiency virus. Ophthal Plast Reconstr Surg. 2000, 16 (3): 206-210. 10.1097/00002341-200005000-00007.CrossRefPubMed
18.
go back to reference Hayashi N, Furihata M, Ohtsuki Y, Ueno H: Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid. Virchows Arch. 1994, 424 (5): 503-509.CrossRefPubMed Hayashi N, Furihata M, Ohtsuki Y, Ueno H: Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid. Virchows Arch. 1994, 424 (5): 503-509.CrossRefPubMed
19.
go back to reference Dowd MB, Kumar RJ, Sharma R, Murali R: Diagnosis and management of sebaceous carcinoma: an Australian experience. ANZ J Surg. 2008, 78 (3): 158-163. 10.1111/j.1445-2197.2007.04393.x.CrossRefPubMed Dowd MB, Kumar RJ, Sharma R, Murali R: Diagnosis and management of sebaceous carcinoma: an Australian experience. ANZ J Surg. 2008, 78 (3): 158-163. 10.1111/j.1445-2197.2007.04393.x.CrossRefPubMed
20.
go back to reference Wolfe JT, Yeatts RP, Wick MR, Campbell RJ, Waller RR: Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol. 1984, 8 (8): 597-606. 10.1097/00000478-198408000-00003.CrossRefPubMed Wolfe JT, Yeatts RP, Wick MR, Campbell RJ, Waller RR: Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol. 1984, 8 (8): 597-606. 10.1097/00000478-198408000-00003.CrossRefPubMed
21.
go back to reference Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993, 15 (3): 532-534. 536-537PubMed Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993, 15 (3): 532-534. 536-537PubMed
22.
go back to reference Draper GJ, Sanders BM, Kingston JE: Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986, 53 (5): 661-671. 10.1038/bjc.1986.110.PubMedCentralCrossRefPubMed Draper GJ, Sanders BM, Kingston JE: Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986, 53 (5): 661-671. 10.1038/bjc.1986.110.PubMedCentralCrossRefPubMed
23.
go back to reference Abbas O, Mahalingam M: Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. J Cutan Pathol. 2009, 36 (6): 613-619. 10.1111/j.1600-0560.2009.01248.x.CrossRefPubMed Abbas O, Mahalingam M: Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. J Cutan Pathol. 2009, 36 (6): 613-619. 10.1111/j.1600-0560.2009.01248.x.CrossRefPubMed
24.
go back to reference Cohen PR, Kohn SR, Kurzrock R: Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991, 90 (5): 606-613. 10.1016/S0002-9343(05)80013-0.CrossRefPubMed Cohen PR, Kohn SR, Kurzrock R: Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991, 90 (5): 606-613. 10.1016/S0002-9343(05)80013-0.CrossRefPubMed
25.
go back to reference Honavar SG, Shields CL, Maus M, Shields JA, Demirci H, Eagle RC: Primary intraepithelial sebaceous gland carcinoma of the palpebral conjunctiva. Arch Ophthalmol. 2001, 119 (5): 764-767.CrossRefPubMed Honavar SG, Shields CL, Maus M, Shields JA, Demirci H, Eagle RC: Primary intraepithelial sebaceous gland carcinoma of the palpebral conjunctiva. Arch Ophthalmol. 2001, 119 (5): 764-767.CrossRefPubMed
26.
go back to reference Feizy V, Toosi S: Relation of basal cell carcinoma to hair dye use. J Am Acad Dermatol. 2009, 61 (3): 532-533. 10.1016/j.jaad.2009.01.040.CrossRefPubMed Feizy V, Toosi S: Relation of basal cell carcinoma to hair dye use. J Am Acad Dermatol. 2009, 61 (3): 532-533. 10.1016/j.jaad.2009.01.040.CrossRefPubMed
27.
go back to reference Boyle R, O'Hagan AH, Donnelly D, Donnelly C, Gordon S, McElwee G, Gavin A: Trends in reported sun bed use, sunburn, sun care knowledge and attitudes in a UK region: results of a survey of the Northern Ireland population. Br J Dermatol. 2010 Boyle R, O'Hagan AH, Donnelly D, Donnelly C, Gordon S, McElwee G, Gavin A: Trends in reported sun bed use, sunburn, sun care knowledge and attitudes in a UK region: results of a survey of the Northern Ireland population. Br J Dermatol. 2010
28.
go back to reference Rao NA, Hidayat AA, McLean IW, Zimmerman LE: Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982, 13 (2): 113-122. 10.1016/S0046-8177(82)80115-9.CrossRefPubMed Rao NA, Hidayat AA, McLean IW, Zimmerman LE: Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982, 13 (2): 113-122. 10.1016/S0046-8177(82)80115-9.CrossRefPubMed
29.
go back to reference Justi RA: Sebaceous carcinoma; report of case developing in area of radiodermatitis. AMA Arch Derm. 1958, 77 (2): 195-200. 10.1001/archderm.1958.01560020047005.CrossRefPubMed Justi RA: Sebaceous carcinoma; report of case developing in area of radiodermatitis. AMA Arch Derm. 1958, 77 (2): 195-200. 10.1001/archderm.1958.01560020047005.CrossRefPubMed
30.
go back to reference Constant E, Leahy MS: Sebaceous cell carcinoma. Plast Reconstr Surg. 1968, 41 (5): 433-437. 10.1097/00006534-196805000-00003.CrossRefPubMed Constant E, Leahy MS: Sebaceous cell carcinoma. Plast Reconstr Surg. 1968, 41 (5): 433-437. 10.1097/00006534-196805000-00003.CrossRefPubMed
31.
go back to reference Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA. 1991, 88 (22): 10124-10128. 10.1073/pnas.88.22.10124.PubMedCentralCrossRefPubMed Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA. 1991, 88 (22): 10124-10128. 10.1073/pnas.88.22.10124.PubMedCentralCrossRefPubMed
32.
go back to reference Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M: TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007, 26 (15): 2157-2165. 10.1038/sj.onc.1210302.CrossRefPubMed Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M: TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007, 26 (15): 2157-2165. 10.1038/sj.onc.1210302.CrossRefPubMed
33.
go back to reference Khan MA, Travis LB, Lynch CF, Soini Y, Hruszkewycz AM, Delgado RM, Holowaty EJ, van Leeuwen FE, Glimelius B, Stovall M, et al.: p53 mutations in cyclophosphamide-associated bladder cancer. Cancer Epidemiol Biomarkers Prev. 1998, 7 (5): 397-403.PubMed Khan MA, Travis LB, Lynch CF, Soini Y, Hruszkewycz AM, Delgado RM, Holowaty EJ, van Leeuwen FE, Glimelius B, Stovall M, et al.: p53 mutations in cyclophosphamide-associated bladder cancer. Cancer Epidemiol Biomarkers Prev. 1998, 7 (5): 397-403.PubMed
34.
go back to reference Martinez R, Roggendorf W, Baretton G, Klein R, Toedt G, Lichter P, Schackert G, Joos S: Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations. Cancer Genet Cytogenet. 2007, 175 (1): 26-34. 10.1016/j.cancergencyto.2007.01.006.CrossRefPubMed Martinez R, Roggendorf W, Baretton G, Klein R, Toedt G, Lichter P, Schackert G, Joos S: Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations. Cancer Genet Cytogenet. 2007, 175 (1): 26-34. 10.1016/j.cancergencyto.2007.01.006.CrossRefPubMed
35.
go back to reference Inga A, Storici F, Darden TA, Resnick MA: Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol Cell Biol. 2002, 22 (24): 8612-8625. 10.1128/MCB.22.24.8612-8625.2002.PubMedCentralCrossRefPubMed Inga A, Storici F, Darden TA, Resnick MA: Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol Cell Biol. 2002, 22 (24): 8612-8625. 10.1128/MCB.22.24.8612-8625.2002.PubMedCentralCrossRefPubMed
36.
go back to reference Joerger AC, Fersht AR: Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene. 2007, 26 (15): 2226-2242. 10.1038/sj.onc.1210291.CrossRefPubMed Joerger AC, Fersht AR: Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene. 2007, 26 (15): 2226-2242. 10.1038/sj.onc.1210291.CrossRefPubMed
37.
go back to reference Funk WD, Pak DT, Karas RH, Wright WE, Shay JW: A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol. 1992, 12 (6): 2866-2871.PubMedCentralCrossRefPubMed Funk WD, Pak DT, Karas RH, Wright WE, Shay JW: A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol. 1992, 12 (6): 2866-2871.PubMedCentralCrossRefPubMed
38.
go back to reference el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B: Definition of a consensus binding site for p53. Nat Genet. 1992, 1 (1): 45-49. 10.1038/ng0492-45.CrossRefPubMed el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B: Definition of a consensus binding site for p53. Nat Genet. 1992, 1 (1): 45-49. 10.1038/ng0492-45.CrossRefPubMed
39.
go back to reference Chen Y, Dey R, Chen L: Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer. Structure. 2010, 18 (2): 246-256. 10.1016/j.str.2009.11.011.PubMedCentralCrossRefPubMed Chen Y, Dey R, Chen L: Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer. Structure. 2010, 18 (2): 246-256. 10.1016/j.str.2009.11.011.PubMedCentralCrossRefPubMed
40.
go back to reference Lemos LB, Santa Cruz DJ, Baba N: Sebaceous carcinoma of the eyelid following radiation therapy. Am J Surg Pathol. 1978, 2 (3): 305-311. 10.1097/00000478-197809000-00007.CrossRefPubMed Lemos LB, Santa Cruz DJ, Baba N: Sebaceous carcinoma of the eyelid following radiation therapy. Am J Surg Pathol. 1978, 2 (3): 305-311. 10.1097/00000478-197809000-00007.CrossRefPubMed
41.
go back to reference Howrey RP, Lipham WJ, Schultz WH, Buckley EG, Dutton JJ, Klintworth GK, Rosoff PM: Sebaceous gland carcinoma: a subtle second malignancy following radiation therapy in patients with bilateral retinoblastoma. Cancer. 1998, 83 (4): 767-771. 10.1002/(SICI)1097-0142(19980815)83:4<767::AID-CNCR20>3.0.CO;2-P.CrossRefPubMed Howrey RP, Lipham WJ, Schultz WH, Buckley EG, Dutton JJ, Klintworth GK, Rosoff PM: Sebaceous gland carcinoma: a subtle second malignancy following radiation therapy in patients with bilateral retinoblastoma. Cancer. 1998, 83 (4): 767-771. 10.1002/(SICI)1097-0142(19980815)83:4<767::AID-CNCR20>3.0.CO;2-P.CrossRefPubMed
42.
go back to reference Forrest AW: Tumors following radiation about the eye. Trans Am Acad Ophthalmol Otolaryngol. 1961, 65: 694-717.PubMed Forrest AW: Tumors following radiation about the eye. Trans Am Acad Ophthalmol Otolaryngol. 1961, 65: 694-717.PubMed
43.
go back to reference Roarty JD, McLean IW, Zimmerman LE: Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988, 95 (11): 1583-1587.CrossRefPubMed Roarty JD, McLean IW, Zimmerman LE: Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988, 95 (11): 1583-1587.CrossRefPubMed
44.
go back to reference Boniuk M, Zimmerman LE: Sebaceous carcinoma of the eyelid, eyebrow, caruncle, and orbit. Trans Am Acad Ophthalmol Otolaryngol. 1968, 72 (4): 619-642.PubMed Boniuk M, Zimmerman LE: Sebaceous carcinoma of the eyelid, eyebrow, caruncle, and orbit. Trans Am Acad Ophthalmol Otolaryngol. 1968, 72 (4): 619-642.PubMed
45.
go back to reference Rundle P, Shields JA, Shields CL, Eagle RC, Singh AD: Sebaceous gland carcinoma of the eyelid seventeen years after irradiation for bilateral retinoblastoma. Eye (Lond). 1999, 13 (Pt 1): 109-110.CrossRef Rundle P, Shields JA, Shields CL, Eagle RC, Singh AD: Sebaceous gland carcinoma of the eyelid seventeen years after irradiation for bilateral retinoblastoma. Eye (Lond). 1999, 13 (Pt 1): 109-110.CrossRef
46.
go back to reference Meadows AT, D'Angio GJ, Mike V, Banfi A, Harris C, Jenkin RD, Schwartz A: Patterns of second malignant neoplasms in children. Cancer. 1977, 40 (4 Suppl): 1903-1911.CrossRefPubMed Meadows AT, D'Angio GJ, Mike V, Banfi A, Harris C, Jenkin RD, Schwartz A: Patterns of second malignant neoplasms in children. Cancer. 1977, 40 (4 Suppl): 1903-1911.CrossRefPubMed
47.
go back to reference Chao AN, Shields CL, Krema H, Shields JA: Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001, 108 (10): 1877-1883. 10.1016/S0161-6420(01)00719-9.CrossRefPubMed Chao AN, Shields CL, Krema H, Shields JA: Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001, 108 (10): 1877-1883. 10.1016/S0161-6420(01)00719-9.CrossRefPubMed
48.
go back to reference Survival rate and risk factors for patients with retinoblastoma in Japan. The Committee for the National Registry of Retinoblastoma. Jpn J Ophthalmol. 1992, 36 (2): 121-131. Survival rate and risk factors for patients with retinoblastoma in Japan. The Committee for the National Registry of Retinoblastoma. Jpn J Ophthalmol. 1992, 36 (2): 121-131.
49.
go back to reference Schlernitzauer DA, Font RL: Sebaceous gland carcinoma of the eyelid. Arch Ophthalmol. 1976, 94 (9): 1523-1525. 10.1001/archopht.1976.03910040357010.CrossRefPubMed Schlernitzauer DA, Font RL: Sebaceous gland carcinoma of the eyelid. Arch Ophthalmol. 1976, 94 (9): 1523-1525. 10.1001/archopht.1976.03910040357010.CrossRefPubMed
50.
go back to reference Bhalla JS, Vashisht S, Gupta VK, Sen AK: Meibomian gland carcinoma in a 20-year-old patient. Am J Ophthalmol. 1991, 111 (1): 114-115.CrossRefPubMed Bhalla JS, Vashisht S, Gupta VK, Sen AK: Meibomian gland carcinoma in a 20-year-old patient. Am J Ophthalmol. 1991, 111 (1): 114-115.CrossRefPubMed
51.
go back to reference Deprez M, Uffer S: Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature. Am J Dermatopathol. 2009, 31 (3): 256-262.PubMed Deprez M, Uffer S: Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature. Am J Dermatopathol. 2009, 31 (3): 256-262.PubMed
52.
go back to reference Mirzamani N, Sundram UN: A case of sebaceous carcinoma diagnosed in an adolescent male. J Cutan Pathol. 2011 Mirzamani N, Sundram UN: A case of sebaceous carcinoma diagnosed in an adolescent male. J Cutan Pathol. 2011
53.
go back to reference Becker K, Goldberg M, Helmbold P, Holbach LM, Loeffler KU, Ballhausen WG: Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas. Br J Dermatol. 2008, 159 (6): 1282-1289. 10.1111/j.1365-2133.2008.08783.x.CrossRefPubMed Becker K, Goldberg M, Helmbold P, Holbach LM, Loeffler KU, Ballhausen WG: Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas. Br J Dermatol. 2008, 159 (6): 1282-1289. 10.1111/j.1365-2133.2008.08783.x.CrossRefPubMed
Metadata
Title
Early onset sebaceous carcinoma
Authors
Dongjin Sung
Sara A Kaltreider
Federico Gonzalez-Fernandez
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2011
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-6-81

Other articles of this Issue 1/2011

Diagnostic Pathology 1/2011 Go to the issue